RhoA inhibitors (CompleGen)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameRhoA inhibitors (CompleGen)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTransforming protein RhoA inhibitors
TargetsTransforming protein RhoA
Therapy Area/IndicationsRespiratory Distress Syndrome, AdultHypertension, PulmonaryRespiratory Tract Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCompleGen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCompleGen Inc
Active IndicationsN/A
Inactive IndicationsRespiratory Distress Syndrome, AdultHypertension, PulmonaryRespiratory Tract Diseases +[4] 

Other Information

ATC CodeN/A
Related LinksN/A